- Category
- Micro (2020-21)
- Udyam number
- UDYAM-RJ-17-0040990

Eramedica Private Limited
About Eramedica Private Limited
Data last updated:
Eramedica Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 November 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24239RJ2020PTC071913. Its GSTIN is 08AAUCA3304L1ZE (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Aizor Life Sciences Private Limited. It is led by directors Manju Khurana and Swarn Kanta Minghlani.
Its last annual general meeting (AGM) was held on 21 July 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4 D 29 Jawahar Nagar, Jaipur, Rajasthan, India – 302004.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.12 Cr, a growth of 64% compared to the previous year. For the same year it recorded a net profit of ₹24,630 (net margin 0.2%) and EBITDA of ₹1.33 Lakh (EBITDA margin 1.2%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
Court records list 1 case involving the company, including 1 filed against it.
Eramedica Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-17-0040990).
Company details
Recognitions & Rankings of Eramedica
Contact details
Eramedica Private Limited's registered office is in Jaipur, Rajasthan. Its e-mail address is in the company report.
- Email
- Registered Address4 D 29 Jawahar Nagar, Jaipur, Rajasthan, India – 302004
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Eramedica Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Eramedica is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Eramedica Private Limited, buy the company report.
Financials of Eramedica Private Limited
FY 2025 filings availableEramedica Private Limited reported revenue of ₹1.12 Cr (up 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 64% growth in the latest year. EBITDA fell 14% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.33 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹24,630 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.2% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Eramedica Private Limited, buy the company report.
Board of directors of Eramedica Private Limited
Eramedica has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manju Khurana | Director | 02 Nov 2020 | 6 Years 0 Months | Current |
| Swarn Kanta Minghlani | Additional Director | 08 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
Eramedica Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| GSL Biotech Private Limited | ₹1.12 Cr (FY 2024) | 51.0% | Pune, Maharashtra, India | |||
| Anglo-Indian Pharmaceuticals Private Limited | ₹1.12 Cr (FY 2025) | 17.0% | Mumbai, Maharashtra, India | |||
| Medicotrans Private Limited | ₹1.12 Cr (FY 2024) | -28.0% | Pune, Maharashtra, India | |||
| Eramedica Private Limitedthis company | ₹1.12 Cr (FY 2025) | ₹24,630 | 0.2% | 64.0% | Jaipur, Rajasthan, India | |
| Gromaxformulations Private Limited | ₹1.12 Cr (FY 2025) | -31.0% | Sriperumbudur, Tamil Nadu, India | |||
| Hermes Animal Health Care Private Limited | ₹1.12 Cr (FY 2024) | -86.0% | Coimbatore, Tamil Nadu, India | |||
| Tricent Pharmaceuticals Private Limited | ₹1.11 Cr (FY 2024) | 7056835.0% | Lucknow, Uttar Pradesh, India |
To see the full peer comparison of Eramedica Private Limited, buy the company report.
Legal cases
Eramedica Private Limited has 1 court case on record: 1 filed against it. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Solan, Himachal Pradesh | Court case (Suit For Recovery) | Filed against the company by M/S JM Laboratories Having Its Office at | Disposed |
To see the full case history of Eramedica Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Eramedica Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Eramedica Private Limited has 1 active EPFO establishment as of Apr 08, 2024.
GST
Eramedica has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAUCA3304L1ZE | Rajasthan | Active | 15 Feb 2021 |
To see the full GST registrations and return filing status of Eramedica Private Limited, buy the company report.
Recent activity
Eramedica Private Limited has 3 board changes on record since 2020: 2 appointments and 1 cessation. The latest: Preeti Khurana ceased to be Director on 08 Jun 2024.
Frequently asked questions
Eramedica is an active private limited company based in Jaipur, Rajasthan, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 November 2020 (6+ years old) and is registered under CIN U24239RJ2020PTC071913.
Eramedica has 2 current directors:
- Manju Khurana - Director
- Swarn Kanta Minghlani - Additional Director
The latest financial statements of Eramedica on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 21 July 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Eramedica is 08AAUCA3304L1ZE, registered in Rajasthan.
The CIN (Corporate Identification Number) of Eramedica is U24239RJ2020PTC071913. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Eramedica has 1 court case on record: 1 filed against it.
Eramedica was incorporated on 02 November 2020, making it 6+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Eramedica by revenue are GSL Biotech Private Limited, Anglo-Indian Pharmaceuticals Private Limited, Medicotrans Private Limited, Gromaxformulations Private Limited, Hermes Animal Health Care Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Preeti Khurana ceased to be Director on 08 Jun 2024. Swarn Kanta Minghlani was appointed as Additional Director on 08 Jun 2024. Manju Khurana was appointed as Director on 02 Nov 2020.
Yes, Eramedica is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-17-0040990).
The registered office of Eramedica is at 4 D 29 Jawahar Nagar, Jaipur, Rajasthan, India – 302004.

